Biologic therapies: Lessons from multiple sclerosis

Digestive Diseases

Volumn 30, Issue 4, 2012, Pages 383-386

  Ghosh, Subrata ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anti adhesion molecule therapy; Multiple sclerosis; Progressive multifocal leukoencephalopathy

Indexed keywords

ALPHA4 INTEGRIN; CD40 ANTIGEN; FINGOLIMOD; GLATIRAMER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23; LAQUINIMOD; NATALIZUMAB; RECOMBINANT BETA INTERFERON; RITUXIMAB; STAT3 PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; USTEKINUMAB; VEDOLIZUMAB;

ARTICLE; BIOLOGICAL THERAPY; CELL MIGRATION; CROHN DISEASE; DEMYELINATION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG WITHDRAWAL; ENTERITIS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REMYELINIZATION; TH1 CELL; TH2 CELL; ULCERATIVE COLITIS; VITAMIN D DEFICIENCY;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOLOGICAL THERAPY; CELL ADHESION MOLECULES; HUMANS; INFLAMMATORY BOWEL DISEASES; MULTIPLE SCLEROSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863940815     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000338131     Document Type: Article

References (15)

1. Gupta G, Gelfand JM, Lewis JD: Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 2005; 129: 819-826.
2. Denny JC, Ritchie MD, Basford MA, Pulley JM, Bastarache L, Brown-Gentry K, et al: PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics 2010; 26: 1205-1210.
3. Blanco-Kelly F, Matesanz F, Alcina A, Teruel M, Diaz-Gallo LM, Gomez-Garcia M, et al: CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibility. PLoS One 2010; 5:e11520.
4. Andersen NN, Caspersen S, Jess T, Munkholm P: Occurrence of demyelinating diseases after anti-TNF treatment of inflammatory bowel disease: a Danish Crohn Colitis database study. J Crohns Colitis 2008; 2: 304-309.
5. Krone B, Grange JM: Paradigms in multiple sclerosis: time for a change, time for a unifying concept. Inflammopharmacol 2011; 19: 187-195.
6. Comabella M, Khoury SJ: Immunopathogenesis of multiple sclerosis. Clin Immunol 2012; 142: 2-8.
7. Colombel JF, Sandborn WJ, Rutgeerts P, Enns R, Hanauer SB, Panaccione R, Schreiber S, Byczkowski D, Li J, Kent JD, Pollack PF: Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Gastroenterology 2007; 132: 52-65.
8. Wiendl H, Hohlfeld R: Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials. Bio-Drugs 2002; 16: 183-200.
9. Caminero A, Comabella M, Montalban X: Tumour necrosis factor alpha, anti-TNF alpha and demyelination revisited: an ongoing story. J Neuroimmunol 2011; 234: 1-6.
10. Khatri B, Barkhof F, Comi G, Hartung HP, Kappos L, Montalban X, et al: Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. Lancet Neurol 2011; 10: 520-529.
11. Bell GM, Reynolds G, Isaacs JD: Biologic therapies in non-rheumatic diseases: lessons for rheumatologists. Nat Rev Rheumatol 2011; 7: 507-516.
12. Ghosh S, Goldin E, Gordon F, Malchow HA, Rask-Madsen J, Rutgeerts P, Vyhnalek P, Zadarova Z, Palmer T, Donoghue S: Natalizumab for active Crohn's disease. N Engl J Med 2003; 348: 24-32.
13. Kappos L, Bates D, Edan G, Eraksoy M, Garcia-Merino A, Grigoriadis N, et al: Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring. Lancet Neurol 2011; 10: 745-758.
14. Vermiere S, Ghosh S, Panes J, Dahlerup J, Luegering A, Sirotiakova J, Strauch U, Burgess G, Spanton J, Martin S, Niezychowski W: The mucosal addressin cell adhesion molecule (MAdCAM) antibody PF-00547,659 in ulcerative colitis: a randomized study. Gut 2011; 60: 1068-1075.
15. Ghosh S, Panaccione R: Anti-adhesion molecule therapy in inflammatory bowel disease. Therap Advances Gastroenterol 2010; 3: 239-258.